Nutrien Ltd. $NTR Shares Sold by Invesco Ltd.

Invesco Ltd. trimmed its position in Nutrien Ltd. (NYSE:NTRFree Report) by 5.7% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 1,259,803 shares of the company’s stock after selling 76,466 shares during the period. Invesco Ltd.’s holdings in Nutrien were worth $73,371,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently bought and sold shares of NTR. Intech Investment Management LLC raised its holdings in Nutrien by 284.0% during the first quarter. Intech Investment Management LLC now owns 69,128 shares of the company’s stock worth $3,430,000 after purchasing an additional 51,126 shares in the last quarter. Belpointe Asset Management LLC acquired a new position in Nutrien during the 1st quarter worth approximately $311,000. Covea Finance raised its stake in shares of Nutrien by 16.5% during the 2nd quarter. Covea Finance now owns 73,500 shares of the company’s stock worth $4,265,000 after buying an additional 10,400 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Nutrien by 1.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 736,996 shares of the company’s stock valued at $36,607,000 after buying an additional 7,194 shares during the period. Finally, Advisors Asset Management Inc. boosted its stake in shares of Nutrien by 20.2% in the second quarter. Advisors Asset Management Inc. now owns 69,551 shares of the company’s stock valued at $4,051,000 after buying an additional 11,704 shares in the last quarter. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Nutrien Stock Performance

Nutrien stock opened at $59.09 on Thursday. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.41 and a quick ratio of 0.89. Nutrien Ltd. has a 12 month low of $43.69 and a 12 month high of $65.08. The company has a fifty day moving average price of $57.87 and a two-hundred day moving average price of $58.48. The company has a market cap of $28.57 billion, a PE ratio of 15.93, a P/E/G ratio of 0.68 and a beta of 0.72.

Nutrien (NYSE:NTRGet Free Report) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.06. Nutrien had a net margin of 6.79% and a return on equity of 7.54%. The company had revenue of $5.82 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same period last year, the firm posted $0.39 EPS. The company’s revenue for the quarter was up 12.3% on a year-over-year basis. Research analysts expect that Nutrien Ltd. will post 3.72 earnings per share for the current year.

Nutrien Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 16th. Shareholders of record on Wednesday, December 31st will be paid a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a yield of 3.7%. The ex-dividend date is Wednesday, December 31st. Nutrien’s payout ratio is presently 58.76%.

Analyst Upgrades and Downgrades

NTR has been the subject of several research analyst reports. Wells Fargo & Company initiated coverage on Nutrien in a research report on Tuesday, November 11th. They issued an “equal weight” rating and a $64.00 price objective for the company. Zacks Research downgraded shares of Nutrien from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 16th. Jefferies Financial Group lowered their target price on shares of Nutrien from $61.00 to $60.00 and set a “hold” rating on the stock in a research report on Tuesday, September 9th. UBS Group reduced their price target on shares of Nutrien from $63.00 to $58.00 and set a “neutral” rating for the company in a research report on Thursday, November 6th. Finally, Bank of America reaffirmed a “neutral” rating and issued a $67.00 price objective on shares of Nutrien in a research note on Tuesday, October 14th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, fourteen have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $62.94.

Check Out Our Latest Stock Analysis on Nutrien

Nutrien Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Further Reading

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.